Groundbreaking Settlement on Behalf of Southern African Gold Miners Suffering From Silicosis & Tuberculosis
May 03, 2018 09:04 ET
|
Hausfeld
WASHINGTON, May 03, 2018 (GLOBE NEWSWIRE) -- Hausfeld is proud to announce a groundbreaking settlement on behalf of Southern African gold miners suffering from occupational lung disease that was...
Oak Therapeutics Announces Results of Bioequivalence Study of Company’s Oral Dissolvable Strip for Tuberculosis
October 03, 2017 09:00 ET
|
CURE Pharmaceutical
OXNARD, Calif., Oct. 03, 2017 (GLOBE NEWSWIRE) -- Oak Therapeutics, a subsidiary of CURE Pharmaceutical (OTCQB:CURR), (“CURE”), a leading disruptive drug delivery technology company, has completed...
CURE Pharmaceutical Subsidiary, Oak Therapeutics, Completes Critical Milestone in Phase 1 of NIH Grant to Develop Oral Dissolvable Strip for Tuberculosis
August 22, 2017 11:19 ET
|
CURE Pharmaceutical
OXNARD, Calif., Aug. 22, 2017 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTCQB:CURR), (“CURE”), a leading disruptive drug delivery technology company, today announced that its subsidiary company, Oak...
Refugees Need to Be Vetted for Health Reasons as Well as Terrorist Connections, States the Association of American Physicians and Surgeons (AAPS)
November 03, 2016 16:00 ET
|
Association of American Physicians and Surgeons
TUCSON, Ariz., Nov. 03, 2016 (GLOBE NEWSWIRE) -- In the argument over immigration policy, candidate Hillary Clinton cites humanitarian concerns, especially for children, notes the Association of...
American Health Council Names Virginia Lipke, RN, MHA, ACRN, CIC to Nursing Board
August 05, 2016 12:20 ET
|
American Health Council
NEW YORK, Aug. 05, 2016 (GLOBE NEWSWIRE) -- Virginia Lipke, an International Infection Control Practitioner at Centers for Disease Control and Prevention, has been selected to join the Nursing...
Hausfeld Announces Class Action Certified for South African Gold Miners in Landmark Case
May 13, 2016 12:53 ET
|
Hausfeld
JOHANNESBURG, South Africa, May 13, 2016 (GLOBE NEWSWIRE) -- The South Gauteng High Court in Johannesburg has certified the first class action in South African history for sick workers, allowing...
Nano Labs Develops Diagnostic Technology to Identify Tuberculosis (TB) Through Novel Nanotechnologies
March 04, 2013 07:00 ET
|
Nano Labs Corp.
DETROIT, March 4, 2013 (GLOBE NEWSWIRE) -- Nano Labs Corp. (OTCQB:CTLE) is pleased to present industry with promising biological diagnostics test results obtained at macro-level, on a miniaturized...
Immune Network to Start Clinical Trial of Oral Mycobacterium Vaccae in Tuberculosis Patients
August 10, 2011 05:00 ET
|
Immune Network Ltd
VANCOUVER, British Columbia, Aug. 10, 2011 (GLOBE NEWSWIRE) -- Immune Network Ltd., (Pink Sheets:IMMFF), reports that its business partner Immunitor company has launched a Phase 2 clinical trial of a...
Herbal TB Immunotherapy to be Presented at Hong Kong Conference
July 07, 2011 10:33 ET
|
Immune Network Ltd
VANCOUVER, British Columbia, July 7, 2011 (GLOBE NEWSWIRE) -- Immune Network Ltd. (Pink Sheets:IMMFF) advises that clinical results from its new tableted form of Immunoxel (Dzherelo) product...
TB Immunotherapy Collaboration Agreement With Stirling Products and Zodiac Capital
May 30, 2011 10:14 ET
|
Immune Network Ltd
Agreement to fast-track introduction of new Immunoxel/Dzherelo tablet as adjunct immunotherapy, especially for MDR-TB
VANCOUVER, British Columbia, May 30, 2011 (GLOBE NEWSWIRE) -- Immune...